Vimarsana
Biggest News Aggregation in the World

Rr Mcl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rr Mcl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rr Mcl Today - Breaking & Trending Today

Ibrutinib Combined With Venetoclax in Patients With Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis Results From the Randomized Phase 3 SYMPATICO Study - Vimarsana News

Ibrutinib Combined With Venetoclax in Patients With Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis Results From the Randomized Phase 3 SYMPATICO Study

Published: February 20, 2024

Michael Wang, MD, presents the primary analysis results from the multinational, randomized, double-blind, phase 3 SYMPATICO study comparing ibrutinib plus venetoclax vs ibrutinib plus placebo in patients with relapsed/refractory mantle cell lymphoma (R/R MCL).

Source: onclive.com
Related Topics:
Ibrutinib Combined With VenetoclaxPatients WithRefractory Mantle Cell LymphomaPrimary Analysis Results FromRandomized PhaseMantle Cell LymphomaRr MclRelapsed Refractory Mantle Cell Lymphoma
Lisocabtagene Maraleucel in R/R MCL: Primary Analysis Results from the MCL Cohort of the Single-Arm, Multicenter, Seamless Design TRANSCEND NHL 001 Study - Vimarsana News

Lisocabtagene Maraleucel in R/R MCL: Primary Analysis Results from the MCL Cohort of the Single-Arm, Multicenter, Seamless Design TRANSCEND NHL 001 Study

Published: December 6, 2023

Alexey Danilov, MD, PhD, reviews data from the TRANSCEND NHL 001 study investigating lisocabtagene maraleucel in patients with relapsed/refractory mantle cell lymphoma.

Source: onclive.com
Related Topics:
Alexey DanilovLisocabtagene MaraleucelInternational Conference On Malignant LymphomaPrimary Analysis ResultsSeamless DesignPartnership WithInternational ConferenceMalignant LymphomaTranscend Nhl 001Relapsed Refractory Mantle Cell LymphomaLiso CelRelapsed Refractory MclMantle Cell LymphomaTranscend Nhl 001 StudyRr MclTranscend Nhl 001 ResultsTranscend Nhl 001 Data